Evidence map›Paper›PMID 22776123›Full record

Trial reportJournal of the American Association for Laboratory Animal Science : JAALAS2012

Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies.

Qiwen Duan, Yanfeng Liu, Carmen J Booth, Sara Rockwell

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Association for Laboratory Animal Science : JAALAS, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Exceptional Repositioning of Dog Dewormer: Fenbendazole Fever.Current issues in molecular biology · 2022
    Review
  3. Article
  4. Double Repositioning: Veterinary Antiparasitic to Human Anticancer.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Biological Evaluation of a Potential Anticancer Agent MethylCancer biotherapy & radiopharmaceuticals · 2020
    Article
  7. Article
  8. Article
  9. Effect of fenbendazole on an autoimmune mouse model.Journal of the American Association for Laboratory Animal Science : JAALAS · 2013
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qiwen DuanDepartment of Therapeutic Radiology, Yale University School of Medicine New Haven, Connecticut, USA.
Yanfeng Liu
Carmen J Booth
Sara Rockwell
Yale University · US

Funding

TUMOR SELECTIVE INACTIVATION OF THE REPAIR PROTEIN AGTP01CA129186 · NCI · YALE UNIVERSITY · PI GLAZER, PETER M · 2007 to 2012
$8.5M
NCI NIH HHS CA129186-03S2NCI NIH HHS P01 CA129186PHS HHS 16359
6 · The paper itself

Abstract

Pinworm infection (oxyuriasis) is a common problem in rodent colonies. Facility-wide prophylactic treatment of all mice with a diet containing therapeutic levels of fenbendazole for several weeks is often used to control pinworm outbreaks. We examined the effect of feeding a therapeutic diet containing 150 ppm fenbendazole on the growth of EMT6 mouse mammary tumors implanted into BALB/c Rw mice. Mice were randomized to receive either a fenbendazole-containing or control diet for 1 wk before tumor cells were injected intradermally in the flanks and throughout tumor growth. Tumor growth was monitored by serial measurements of tumor diameters from the time tumors became palpable until they reached 1000 mm3. The medicated diet did not alter tumor growth, invasion, or metastasis. When tumors reached volumes of approximately 100 mm3, some were irradiated locally with 10 Gy of X-rays. Irradiation significantly delayed tumor growth; fenbendazole did not alter the radiation-induced growth delay. However, cell culture studies showed that fenbendazole concentrations not far above those expected in the tissues of mice on this diet altered the growth of the tumor cells in culture. Recent data from other laboratories also have demonstrated effects of fenbendazole that could complicate experiments. Care should therefore be exercised in deciding whether chow containing fenbendazole should be administered to mouse colonies being used in cancer research.

Indexed as

Animal FeedAnimalsAnticarcinogenic AgentsAntinematodal AgentsCell Line, TumorFemaleFenbendazoleMammary Neoplasms, AnimalMammary Neoplasms, ExperimentalMiceMice, Inbred BALB COxyuriasisRodent DiseasesAnticarcinogenic AgentsAntinematodal AgentsFenbendazole

Identifiers

PMID22776123
PMCPMC3314526
OpenAlexW1817627577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.